Immunomonitoring of MSC-Treated GvHD Patients Reveals Only Moderate Potential for Response Prediction but Indicates Treatment Safety.
对接受 MSC 治疗的 GvHD 患者进行免疫监测显示，其对疗效预测的潜力仅为中等，但表明治疗安全
期刊:Molecular Therapy-Methods & Clinical Development
影响因子:4.7
doi:10.1016/j.omtm.2018.02.001
Keto Joni, Kaartinen Tanja, Salmenniemi Urpu, Castrén Johanna, Partanen Jukka, Hänninen Arno, Korhonen Matti, Lähteenmäki Kaarina, Itälä-Remes Maija, Nystedt Johanna
